**Question:** Thalassemia gives protection against-

A. Malaria
B. Hepatitis
C. Dengue
D. Sickle cell anemia

**Core Concept:** Thalassemia is a group of inherited blood disorders characterized by reduced production of hemoglobin and affected red blood cells. In thalassemia, the production of globin chains (α-globin and β-globin chains) in red blood cells is altered, leading to reduced hemoglobin synthesis and impaired red blood cell maturation.

**Why the Correct Answer is Right:** Thalassemia provides protection against malaria due to the reduced production of hemoglobin. Malaria is a parasitic infection caused by Plasmodium species, which requires the presence of normal hemoglobin for survival and multiplication. In individuals with thalassemia, the reduced hemoglobin levels prevent the parasite from thriving and causing severe malaria symptoms.

**Why Each Wrong Option is Incorrect:**

A. Malaria is not the only infectious disease that can cause severe anemia, and thalassemia patients may still be affected by malaria but with milder symptoms due to reduced parasite proliferation.

B. Hepatitis is a viral infection affecting the liver, causing inflammation and liver damage. It is unrelated to hemoglobin production or red blood cell function, making this option incorrect.

C. Dengue is a viral infection transmitted by mosquitoes, causing flu-like symptoms and potentially leading to severe complications. Although thalassemia patients may have milder dengue symptoms, it is not directly related to hemoglobin production or red blood cell function.

D. Sickle cell anemia is a separate genetic disorder characterized by abnormal hemoglobin (Hb S) and red blood cell deformity, leading to pain crises, organ damage, and reduced life expectancy. Thalassemia and sickle cell anemia are distinct disorders and have different mechanisms of protection against specific infections.

**Clinical Pearl:** While thalassemia provides protection against severe malaria, it may not prevent all types of infections or complications associated with the disease itself. Regular monitoring and appropriate management are essential for thalassemia patients to ensure optimal health outcomes.